Drugs affecting the gastrointestinal system

(5S,12S)-Dihydroxy-(6E,8E,10E,14Z)-eicosatetraenoic acid.

A natural resorcylic lactone derived from fungi that selectively inhibits purified TAK1 (IC₅₀ = 8.1 nM when co-expressed with the TAK1-binding protein, TAB1) irreversibly blocks IL-1-induced activation of TAK1, NF-&kappaB, and JNK/p38

A natural resorcylic lactone derived from fungi that selectively inhibits purified TAK1 (IC₅₀ = 8.1 nM when co-expressed with the TAK1-binding protein, TAB1) irreversibly blocks IL-1-induced activation of TAK1, NF-&kappaB, and JNK/p38

(5Z)-7-Oxo-Zeaenol

(5Z)-7-Oxo-Zeaenol

(5Z,2E)-CU-3 is a potent and selective inhibitor against the α-isozyme of DGK with an IC 50 value of 0.6 μM, competitively inhibits the affinity of DGKα for ATP with a K m value of 0.48 mM. (5Z,2E)-CU-3 targets the catalytic region, but not the

(5Z,2E)-CU-3 is a potent and selective inhibitor against the α-isozyme of DGK with an IC 50 value of 0.6 μM, competitively inhibits the affinity of DGKα for ATP with a K m value of 0.48 mM. (5Z,2E)-CU-3 targets the catalytic region, but not the

(5Z,2E)-CU-3 is a potent and selective inhibitor against the α-isozyme of DGK with an IC 50 value of 0.6 μM, competitively inhibits the affinity of DGKα for ATP with a K m value of 0.48 mM. (5Z,2E)-CU-3 targets the catalytic region, but not the

(5Z,2E)-CU-3 is a potent and selective inhibitor against the α-isozyme of DGK with an IC 50 value of 0.6 μM, competitively inhibits the affinity of DGKα for ATP with a K m value of 0.48 mM. (5Z,2E)-CU-3 targets the catalytic region, but not the

(5Z,2E)-CU-3 is a potent and selective inhibitor against the α-isozyme of DGK with an IC 50 value of 0.6 μM, competitively inhibits the affinity of DGKα for ATP with a K m value of 0.48 mM. (5Z,2E)-CU-3 targets the catalytic region, but not the

(6,6)Carbon Nanobelt Bis(tetrahydrofuran) Adduct.

(6-(3-((tert-Butyldimethylsilyloxy)methyl)pyrrolidin-1-yl)-2-fluoropyridin-3-yl)methanol.